ROSWELL PARK CANCER INSTITUTE will collaborate with GenomOncology to develop an informatics solution that enables the association of next-generation sequencing results with knowledge resources to define actionable mutations.
ROCHE SERVICIOS S.A., a Roche affiliate, and Cancer Genetics Inc. have entered into a three-year agreement to expand molecular diagnostic cancer testing in Central America and the Caribbean.
THE DUKE-NUS GRADUATE MEDICAL SCHOOL Singapore has partnered with ImaginAb Inc. to establish a joint corporate laboratory to develop new in vivo molecular imaging agents to study cancer biology and immune function.
NORTH SHORE-LIJ CANCER INSTITUTE opened a $47 million radiation therapy facility.
MARGARET DIMOND was named president of the Karmanos Cancer Hospital, effective immediately.
JOHN CZAJKOWSKI, NCI deputy director for management, has accepted a position as executive dean of administration at Harvard Medical School. His start date will be June 2.
Victor Dzau, chancellor of health affairs at Duke University and president and CEO of the Duke University Health System, was named president of the Institute of Medicine.
FDA needs to improve its access to data if it is to manage drug shortages more effectively, the Government Accountability Office concluded.
Enrollment in NCI-sponsored National Clinical Trials Network clinical trials will drop to about 17,500 this fiscal year, the network groups have been told by NCI officials.
NCI has launched a pilot study to assess whether assigning cancer patients treatment based on the genetic characteristics of their disease can improve outcomes for patients with advanced metastatic solid tumors.
